Novel Bispecific Antibody Tovecimig Shows Efficacy in Biliary Tract Cancer, Though Survival Benefit Remains Ambiguous
By Medical News Desk October 24, 2026 In a significant development for the treatment of aggressive gastrointestinal malignancies, results from the phase II/III COMPANION-002 clinical trial have offered a nuanced…












